Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA and glioma

P de Moerloose, M Jeannet, A Martin-Achard

    Tissue Antigens
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Human Leukocyte Antigen (HLA) typing in glioma patients showed no significant antigen frequency differences compared to healthy individuals after statistical correction. This suggests HLA types Bw35 and DRw1 are not strongly associated with glioma risk.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical consequences of sensitisation to minor histocompatibility antigens before allogeneic bone marrow transplantation.

    Bone marrow transplantation·1998
    Same author

    [25 years allogenic bone marrow transplantation in Basel: 1973-1998].

    Schweizerische medizinische Wochenschrift·1998
    Same author

    [10 years Swiss bone marrow donor registry].

    Schweizerische medizinische Wochenschrift·1998
    Same author

    HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation.

    Transplantation·1998
    Same author

    Characterisation of the cytotoxic alloresponse of cord blood.

    Bone marrow transplantation·1998
    Same author

    Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation.

    Leukemia & lymphoma·1998

    Area of Science:

    • Immunogenetics
    • Neuro-oncology

    Background:

    • Gliomas are primary brain tumors with complex etiology.
    • Human Leukocyte Antigen (HLA) genes play a crucial role in immune response and have been investigated in various cancers.

    Purpose of the Study:

    • To investigate the association between specific Human Leukocyte Antigen (HLA) antigen frequencies and glioma in a patient cohort.
    • To compare HLA antigen frequencies in glioma patients with those in a healthy control group.

    Main Methods:

    • Human Leukocyte Antigen (HLA) typing was performed on 80 glioma patients.
    • Antigen frequencies were compared between the patient group and 176 normal controls.
    • Statistical analysis included P value correction for multiple comparisons.

    Main Results:

    Related Experiment Videos

    • A preliminary observation indicated increased phenotypic frequencies of HLA-Bw35 and HLA-DRw1 in glioma patients.
    • However, after correcting for the 35 antigens tested, these observed differences did not reach statistical significance.
    • No significant association was found between the tested HLA antigen frequencies and glioma.

    Conclusions:

    • The study did not find a statistically significant association between the investigated HLA antigen frequencies and glioma.
    • Further research with larger cohorts or different HLA loci may be warranted to explore potential immunogenetic links to glioma.